Are women more susceptible than men to drug-induced QT prolongation? Concentration-QTc modelling in a phase 1 study with oral rac-sotalol
Are women more susceptible than men to drug-induced QT prolongation? Concentration-QTc modelling in a phase 1 study with oral rac-sotalol
复制标题
DOI:
10.1111/bcp.12201
复制
发表时间:
2014-03-01
影响因子:
3.4
通讯作者:
Sarapa, Nenad
中科院分区:
文献类型:
--
作者:
Darpo, Borje;Karnad, Dilip R.;Sarapa, Nenad
AimTo study the differences in QT(c) interval on ECG in response to a single oral dose of rac-sotalol in men and women.MethodsContinuous 12-lead ECGs were recorded in 28 men and 11 women on a separate baseline day and following a single oral dose of 160mg rac-sotalol on the following day. ECGs were extracted at prespecified time points and upsampled to 1000Hz and analyzed manually in a central ECG laboratory on the superimposed median beat. Concentration-QTc analyses were performed using a linear mixed effects model.ResultsRac-sotalol produced a significant reduction in heart rate in men and in women. An individual correction method (QT(c)I) most effectively removed the heart rate dependency of the QT(c) interval. Mean QT(c)I was 10 to 15 ms longer in women at all time points on the baseline day. Rac-sotalol significantly prolonged QT(c)I in both genders. The largest mean change in QT(c)I (QT(c)I) was greater in females (68 ms (95% confidence interval (CI) 59, 76 ms) vs. 27 ms (95% CI 22, 32 ms) in males). Peak rac-sotalol plasma concentration was higher in women than in men (mean C-max 1.8gml(-1) (range 1.1-2.8) vs. 1.4gml(-1) (range 0.9-1.9), P = 0.0009). The slope of the concentration-QT(c)I relationship was steeper in women (30ms per gml(-1)vs. 23ms per gml(-1) in men; P = 0.0135).ConclusionsThe study provides evidence for a greater intrinsic sensitivity to rac-sotalol in women than in men for drug-induced delay in cardiac repolarization.